FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384927277> ?p ?o ?g. }

• W4384927277 endingPage "109817" @default.
• W4384927277 startingPage "109817" @default.
• W4384927277 abstract "Reirradiation with stereotactic body radiotherapy (SBRT) for patients with primary or secondary lung malignancies represents an appealing definitive approach, but its feasibility and safety are not well defined. The purpose of this study was to investigate the tumor control probability (TCP) and toxicity for patients receiving reirradiation with SBRT.Eligible patients with recurrence of primary or secondary lung malignancies from our hospital were subjected to reirradiation with SBRT, and PubMed- and Embase-indexed articles were reviewed. The patient characteristics, pertinent SBRT dosimetric details, local tumor control, and toxicities were extracted. The logistic dose-response models were compared for TCP and overall survival (OS) in terms of the physical dose and three-, four-, and five-fraction equivalent doses.The data of 17 patients from our hospital and 195 patients extracted from 12 articles were summarized. Reirradiation with SBRT yielded 2-year estimates of 80% TCP for doses of 50.10 Gy, 55.85 Gy, and 60.54 Gy in three, four, and five fractions, respectively. The estimated TCP with common fractionation schemes were 50%, 60%, and 70% for 42.04 Gy, 47.44 Gy, and 53.32 Gy in five fractions, respectively. Similarly, the 2-year estimated OS was 50%, 60%, and 70% for 41.62 Gy, 46.88 Gy, and 52.55 Gy in five fractions, respectively. Central tumor localization may be associated with severe toxicity.Reirradiation with SBRT doses of 50-60 Gy in 3-5 fractions is feasible for appropriately selected patients with recurrence of peripheral primary or secondary lung malignancies, but should be carefully considered for centrally-located tumors due to potentially severe toxicity. Further studies are warranted for optimal dose/fractionation schedules and more accurate selection of patients suitable for reirradiation with SBRT." @default.
• W4384927277 created "2023-07-22" @default.
• W4384927277 creator A5007015662 @default.
• W4384927277 creator A5017269486 @default.
• W4384927277 creator A5019024344 @default.
• W4384927277 creator A5030769859 @default.
• W4384927277 creator A5036930387 @default.
• W4384927277 creator A5037947055 @default.
• W4384927277 creator A5042790324 @default.
• W4384927277 creator A5043841525 @default.
• W4384927277 creator A5061514334 @default.
• W4384927277 creator A5064524833 @default.
• W4384927277 creator A5076502639 @default.
• W4384927277 creator A5085787232 @default.
• W4384927277 creator A5090889094 @default.
• W4384927277 creator A5090934958 @default.
• W4384927277 date "2023-10-01" @default.
• W4384927277 modified "2023-09-26" @default.
• W4384927277 title "Reirradiation with Stereotactic Body Radiotherapy for Primary or Secondary Lung Malignancies: Tumor Control Probability and Safety Analyses" @default.
• W4384927277 cites W1158033259 @default.
• W4384927277 cites W1891590976 @default.
• W4384927277 cites W1976385503 @default.
• W4384927277 cites W1977792423 @default.
• W4384927277 cites W1980489978 @default.
• W4384927277 cites W1993072874 @default.
• W4384927277 cites W1993461532 @default.
• W4384927277 cites W1997192472 @default.
• W4384927277 cites W1998090597 @default.
• W4384927277 cites W2001345300 @default.
• W4384927277 cites W2002006779 @default.
• W4384927277 cites W2008063770 @default.
• W4384927277 cites W2008118429 @default.
• W4384927277 cites W2009643556 @default.
• W4384927277 cites W2011118826 @default.
• W4384927277 cites W2031493814 @default.
• W4384927277 cites W2043853873 @default.
• W4384927277 cites W2050970412 @default.
• W4384927277 cites W2094006278 @default.
• W4384927277 cites W2094800966 @default.
• W4384927277 cites W2098354451 @default.
• W4384927277 cites W2100552035 @default.
• W4384927277 cites W2101859975 @default.
• W4384927277 cites W2122587572 @default.
• W4384927277 cites W2122712849 @default.
• W4384927277 cites W2128366510 @default.
• W4384927277 cites W2130252630 @default.
• W4384927277 cites W2136372726 @default.
• W4384927277 cites W2151020778 @default.
• W4384927277 cites W2159746573 @default.
• W4384927277 cites W2198325818 @default.
• W4384927277 cites W2340060096 @default.
• W4384927277 cites W2531806359 @default.
• W4384927277 cites W2549005298 @default.
• W4384927277 cites W2756532344 @default.
• W4384927277 cites W2761351587 @default.
• W4384927277 cites W2765395057 @default.
• W4384927277 cites W2772995846 @default.
• W4384927277 cites W2783886889 @default.
• W4384927277 cites W2790444843 @default.
• W4384927277 cites W2805581338 @default.
• W4384927277 cites W2806999200 @default.
• W4384927277 cites W2810908304 @default.
• W4384927277 cites W2884159952 @default.
• W4384927277 cites W2888582229 @default.
• W4384927277 cites W2899158615 @default.
• W4384927277 cites W2926245852 @default.
• W4384927277 cites W2939770857 @default.
• W4384927277 cites W2942776083 @default.
• W4384927277 cites W2944301866 @default.
• W4384927277 cites W2970506858 @default.
• W4384927277 cites W2970616230 @default.
• W4384927277 cites W2997721110 @default.
• W4384927277 cites W3003663379 @default.
• W4384927277 cites W3019546741 @default.
• W4384927277 cites W3023375271 @default.
• W4384927277 cites W3035745009 @default.
• W4384927277 cites W3036247197 @default.
• W4384927277 cites W3044248056 @default.
• W4384927277 cites W3092338402 @default.
• W4384927277 cites W3113976846 @default.
• W4384927277 cites W3123392454 @default.
• W4384927277 cites W3128646645 @default.
• W4384927277 cites W3129275303 @default.
• W4384927277 cites W3143418719 @default.
• W4384927277 cites W3158093472 @default.
• W4384927277 cites W3162592453 @default.
• W4384927277 cites W3199515001 @default.
• W4384927277 cites W4225158397 @default.
• W4384927277 cites W995321150 @default.
• W4384927277 doi "https://doi.org/10.1016/j.radonc.2023.109817" @default.
• W4384927277 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37480993" @default.
• W4384927277 hasPublicationYear "2023" @default.
• W4384927277 type Work @default.
• W4384927277 citedByCount "0" @default.
• W4384927277 crossrefType "journal-article" @default.
• W4384927277 hasAuthorship W4384927277A5007015662 @default.
• W4384927277 hasAuthorship W4384927277A5017269486 @default.
• W4384927277 hasAuthorship W4384927277A5019024344 @default.

• next